• ABPI Website
  • Media
  • ABPI response to health and social care committee report on vaccination

ABPI response to health and social care committee report on vaccination

The Health and Social Care Committee has published its report Prevention in health and social care: vaccination.  

We welcome the Committee’s comprehensive report and look forward to seeing the forthcoming NHS vaccination strategy, which we hope will put these recommendations into action without delay. Ben Lucas, Managing Director, MSD & ABPI Board member

Ben Lucas, Managing Director at MSD and ABPI Board member, gave evidence to the inquiry on behalf of the ABPI. He said:

“The UK has historically had a strong record on vaccination, so it is frustrating to see rates going in the wrong direction when better preventative measures could ease wider pressures on the NHS. To get back on track, we must look at the whole immunisation journey, from development, to assessment, through to getting vaccines to those who need them.

“Firstly, we must fix the slow and bureaucratic set up of clinical trials to streamline innovation. Next, we need to ensure our regulators and independent scientific advisers have the resources they need to properly assess new vaccines quickly. Finally, we need the right data and healthcare teams in place to deliver flexible vaccination services tailored to the needs of local communities and underserved populations.

“We welcome the Committee’s comprehensive report and look forward to seeing the forthcoming NHS vaccination strategy, which we hope will put these recommendations into action without delay.”

 

TAGS
  • Vaccines

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.